Cancer. Potential of the synthetic lethality principle.

Cancer. Potential of the synthetic lethality principle.

Elucidating the first principles of synthetic lethality in cancer, including biological context, will assist clinical translation.

Bibliographic Details
Main Authors:	Nijman, S, Friend, S
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Synthetic lethal vulnerabilities of cancer.
by: Fece de la Cruz, F, et al.
Published: (2015)

Synthetic lethality: general principles, utility and detection using genetic screens in human cells.
by: Nijman, S
Published: (2011)

The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality
by: Chandler Bray, et al.
Published: (2023-09-01)

Breast Cancer Predisposition Genes and Synthetic Lethality
by: Hannah E. Neiger, et al.
Published: (2021-05-01)

CRISPR Screens in Synthetic Lethality and Combinatorial Therapies for Cancer
by: Laia Castells-Roca, et al.
Published: (2021-03-01)

Epigenetic based synthetic lethal strategies in human cancers
by: Aiai Gao, et al.
Published: (2020-09-01)

Exploiting synthetic lethal interactions for targeted cancer therapy
by: Reinhardt, H. Christian, et al.
Published: (2012)

Synthetic Lethality in Lung Cancer—From the Perspective of Cancer Genomics
by: Iwao Shimomura, et al.
Published: (2019-03-01)

Cancer Metabolism as a Therapeutic Target: Metabolic Synthetic Lethality.
by: Bensaad, K, et al.
Published: (2013)

The power and the promise of synthetic lethality for clinical application in cancer treatment
by: Qian-Wen Liu, et al.
Published: (2024-03-01)

The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy
by: Victor M. Matias-Barrios, et al.
Published: (2023-01-01)

Synthetic lethal approaches to target cancers with loss of PTEN function
by: Ayse Ertay, et al.
Published: (2023-11-01)

Development of Metabolic Synthetic Lethality and Its Implications for Thyroid Cancer
by: Sang-Hyeon Ju, et al.
Published: (2022-02-01)

Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
by: Salvatore Benfatto, et al.
Published: (2021-08-01)

Synthetic lethality guiding selection of drug combinations in ovarian cancer.
by: Andreas Heinzel, et al.
Published: (2019-01-01)

Overview of Ferroptosis and Synthetic Lethality Strategies
by: Yuko Kinowaki, et al.
Published: (2021-08-01)

Synthetic Lethality Targeting Polθ
by: Małgorzata Drzewiecka, et al.
Published: (2022-06-01)

Protocol for Comprehensive Synthetic Lethality Screens
by: Damia Romero-Moya, et al.
Published: (2020-06-01)

The tumor therapy landscape of synthetic lethality
by: Biyu Zhang, et al.
Published: (2021-02-01)

A synthetic lethal screen identifies HDAC4 as a potential target in MELK overexpressing cancers
by: Lin Zhou, et al.
Published: (2021-09-01)

Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response
by: Shaoli Das, et al.
Published: (2019-10-01)

RAD52 as a Potential Target for Synthetic Lethality-Based Anticancer Therapies
by: Monika Toma, et al.
Published: (2019-10-01)

Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment.
by: Chan, N, et al.
Published: (2010)

The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
by: Meiyi Ge, et al.
Published: (2024-03-01)

MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?
by: Tingting Zhang, et al.
Published: (2020-05-01)

Drug–drug synthetic lethality to combat cancer: From bench to bedside
by: Yu Chen, et al.
Published: (2023-05-01)

The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
by: Shuangying Li, et al.
Published: (2022-10-01)

Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
by: Win Topatana, et al.
Published: (2020-09-01)

Synthetic Lethality Approaches in Acute Lymphoblastic Leukemia
by: Francisco Alejandro Lagunas-Rangel, et al.
Published: (2023-12-01)

Harnessing Synthetic Lethal Interactions for Personalized Medicine
by: Grace S. Shieh
Published: (2022-01-01)

Paralog-based synthetic lethality: rationales and applications
by: Yucui Xin, et al.
Published: (2023-06-01)

Mslar: Microbial synthetic lethal and rescue database.
by: Sen-Bin Zhu, et al.
Published: (2023-06-01)

Nitric Oxide: Genomic Instability And Synthetic Lethality
by: Vasily A. Yakovlev
Published: (2015-08-01)

In Silico Screening Identifies a Novel Potential PARP1 Inhibitor Targeting Synthetic Lethality in Cancer Treatment
by: Jian Li, et al.
Published: (2016-02-01)

Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.
by: Asim, M, et al.
Published: (2017)

Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts
by: Maria Michela Pallotta, et al.
Published: (2024-03-01)

SL-scan identifies synthetic lethal interactions in cancer using metabolic networks
by: Ehsan Zangene, et al.
Published: (2023-09-01)

Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer
by: Alexander Y. Deneka, et al.
Published: (2020-01-01)

Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy
by: Ananna Bhadra Arna, et al.
Published: (2023-01-01)

Combinatorial targeting of Hippo-STRIPAK and PARP elicits synthetic lethality in gastrointestinal cancers
by: Liwei An, et al.
Published: (2022-05-01)